Dr. Atif’s primary research interests lie in the development of a safe and effective treatment for pediatric and adult ischemic stroke and also neurogenic tumors (neuroblastoma, glioblastoma, astrocytoma) using neurosteroid progesterone and its metabolite allopregnanolone as treatments.
In collaboration with Emory Institute for Drug Discovery (EIDD), Fahim is working to develop an emergency field treatment (such as the battlefield) for traumatic brain injury (TBI) by developing more watersoluble and stable analogue/pro-drug of progesterone.
The author of 33 peer-reviewed publications, he is also the holder of a patent, filed jointly with Dr. Stein.
Education and Professional Experience
Fahim Atif earned his M.Sc. (2001) and Ph.D. (2006), both in Toxicology, from Hamdard University, New Delhi, India.
He was recruited to the Division of Neurosurgery, University of Nebraska where he served a year as a postdoctoral fellow, studying mechanisms of spinal cord injury.
He then continued postdoctoral work here at Emory, mentored by Dr. Donald Stein.
Still a member of the Brain Research Laboratory, Dr. Atif is now an Assistant Professor in the Department of Emergency Medicine, Emory School of Medicine.